Compass Therapeutics Inc.
NASDAQ:CMPX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
US |
|
Piramal Enterprises Ltd
NSE:PEL
|
IN |
|
A
|
APact Co Ltd
KOSDAQ:200470
|
KR |
|
U
|
U-Tech Co Ltd
KOSDAQ:178780
|
KR |
|
UeSTRA Hannoversche Verkehrsbetriebe AG
F:HVB
|
DE |
|
R
|
Rand Mining Ltd
ASX:RND
|
AU |
|
EFG Hermes Holdings SAE
LSE:EFGD
|
EG |
|
Poxel SA
PAR:POXEL
|
FR |
|
Teaminvest Private Group Ltd
ASX:TIP
|
AU |
|
M
|
M N C Wireless Bhd
KLSE:MNC
|
MY |
|
C
|
Catalano Seafood Ltd
ASX:CSF
|
AU |
|
Intexa SA
PAR:ITXT
|
FR |
|
P
|
Pineapple Resources Bhd
KLSE:PINEAPP
|
MY |
|
Alkami Technology Inc
NASDAQ:ALKT
|
US |
|
Microbix Biosystems Inc
TSX:MBX
|
CA |
|
G
|
Goodtech ASA
F:6FO
|
NO |
|
A
|
Asiasoft Corporation PCL
SET:AS
|
TH |
|
T
|
Tanachira Retail Corporation Co Ltd
SET:TAN
|
TH |
|
Imaflex Inc
XTSX:IFX
|
CA |
|
B
|
British Land Company PLC
F:BLD
|
UK |
|
Select Sands Corp
OTC:SLSDF
|
CA |
|
A
|
Atea ASA
XMUN:MKL
|
NO |
|
Advent Technologies Holdings Inc
NASDAQ:ADN
|
US |
Bankruptcy Probability
Compass Therapeutics Inc.'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Compass Therapeutics Inc. Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
437.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
88.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
57.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Compass Therapeutics Inc.'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Compass Therapeutics Inc. has no debt.
You can find a full breakdown on its Balance Sheet.
